Abstract
Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002-2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019. However, little is currently known about the biology of SARS-CoV-2. Here, using SARS-CoV-2 S protein pseudovirus system, we confirm that human angiotensin converting enzyme 2 (hACE2) is the receptor for SARS-CoV-2, find that SARS-CoV-2 enters 293/hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients' sera show limited cross-neutralization, suggesting that recovery from one infection might not protect against the other. Our results present potential targets for development of drugs and vaccines for SARS-CoV-2.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiotensin-Converting Enzyme 2
-
Antibodies, Viral / immunology*
-
Betacoronavirus / chemistry
-
Betacoronavirus / immunology
-
Betacoronavirus / physiology*
-
Broadly Neutralizing Antibodies / immunology*
-
COVID-19
-
Calcium Channels / metabolism
-
Cathepsin L / metabolism
-
Cathepsins / antagonists & inhibitors
-
Cathepsins / metabolism
-
Cell Fusion
-
Coronavirus Infections / immunology
-
Cross Reactions
-
Endocytosis
-
Giant Cells / physiology
-
HEK293 Cells
-
Humans
-
Neutralization Tests
-
Pandemics
-
Peptidyl-Dipeptidase A / metabolism
-
Phosphatidylinositol 3-Kinases / metabolism
-
Pneumonia, Viral / immunology
-
Protein Domains
-
Protein Multimerization
-
Receptors, Virus / metabolism
-
SARS-CoV-2
-
Severe Acute Respiratory Syndrome / immunology
-
Severe acute respiratory syndrome-related coronavirus / immunology
-
Spike Glycoprotein, Coronavirus / chemistry
-
Spike Glycoprotein, Coronavirus / immunology*
-
Spike Glycoprotein, Coronavirus / metabolism*
-
Trypsin / metabolism
-
Virus Internalization*
Substances
-
Antibodies, Viral
-
Broadly Neutralizing Antibodies
-
Calcium Channels
-
Receptors, Virus
-
Spike Glycoprotein, Coronavirus
-
TPCN2 protein, human
-
spike glycoprotein, SARS-CoV
-
spike protein, SARS-CoV-2
-
PIKFYVE protein, human
-
Cathepsins
-
Peptidyl-Dipeptidase A
-
ACE2 protein, human
-
Angiotensin-Converting Enzyme 2
-
Trypsin
-
Cathepsin L